Treatment of Refractory Colorectal Cancer: Regorafenib vs. TAS-102

Jeong, JH; Hong, YS; Kim, TW

Kim, TW (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.

CURRENT COLORECTAL CANCER REPORTS, 2017; 13 (4): 325

Abstract

Purpose of Review This paper reviews the development, mechanism of action, clinical efficacy, and safety of regorafenib and TAS-102. Through this revi......

Full Text Link